Chiquita Brooks-LaSure, CMS administrator (Chip Somodevilla/Getty Images)
Pharma companies to remain mum on CMS' initial offers next week for the first year of IRA negotiations
One of the biggest (if not the single biggest) gripe that the pharma industry has with the Inflation Reduction Act is that it considers the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
